AusPAR Wegovy

Australian Public Assessment Report

AusPAR

AusPAR Wegovy [PDF, 2.48 MB]

AusPAR Wegovy [Word, 8.74 MB]

Attachment Product information for Wegovy [PDF, 1018.02 KB]

Attachment Product information for Wegovy [Word, 903.17 KB]

Device/Product Name

Wegovy

Active ingredients

Semaglutide

AusPAR Date

4 September 2024

Published

5 September 2024

Submission Number

PM-2021-00612-1-5

Submission Type

Extension of indications

Decision

Approved